Efficacy of Mirikizumab in Comparison to Ustekinumab in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 3 VIVID-1 Study

Authors
Category Primary study
JournalZeitschrift fur Gastroenterologie
Year 2024
This article has no abstract
Epistemonikos ID: 53ddacfddff729734dc0f2e396865bf4fb765e03
First added on: Feb 17, 2025